Insider filing · XENE
Ian Mortimer
PRESIDENT, CEO & INTERIM CFO
profile →
Xenon Pharmaceuticals Inc.
XENE · Healthcare · 12 filings in 24 months
ticker →
Ian Mortimer sold $1.7M of Xenon Pharmaceuticals (XENE)
Executed Jan 2, disclosed Jan 2, the same day.
Value, as filed
$1.7M
37,938 sh × $44.40
Executed
Jan 2
the trade date, as filed
Disclosed
Jan 2
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
IMIan Mortimer (PRESIDENT, CEO & INTERIM CFO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $17.0M of XENE (281,269 sh across 10 lots, as filed), executed Mar 9.
The name
XENEHealthcare · Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therap…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Ian Mortimer in XENE
XENESALE
Xenon Pharmaceuticals Inc.
$404K7,308 sh × $55.23
Exec Mar 13
Filed Mar 13 · 5:30 PM ET XENESALE Xenon Pharmaceuticals Inc. $17.0M
281,269 sh across 10 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET XENESALE Xenon Pharmaceuticals Inc. $1.0M
23,195 sh across 2 lots
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET XENESALE Xenon Pharmaceuticals Inc. $1.0M
25,000 sh × $40.16
Exec Oct 1 2025
Filed Oct 1 2025 · 5:30 PM ET XENESALE Xenon Pharmaceuticals Inc. $2.2M
53,851 sh across 3 lots
Exec Jan 23 2025
Filed Jan 27 2025 · 5:30 PM ET